UNLABELLED: Familial glucocorticoid deficiency (FGD) is a heterogeneous condition of isolated glucocorticoid deficiency due to adrenocorticotropic hormone (ACTH) resistance. Patients have adrenal failure with normal electrolytes. We report two Arab children with different forms of FGD, in whom the diagnosis was initially masked by their acute illness and discuss the reasons for the delay in the diagnosis of FGD in both patients. Patient 1 presented at 12 days with Serratia sepsis. She received hydrocortisone for septic shock and needed dexamethasone courses to wean her off ventilation. At 13 weeks, she had normal electrolytes, low cortisol and high ACTH in keeping with FGD. A homozygous missense mutation (T159) in MC2R confirmed the diagnosis of FGD type 1. Patient 2 was admitted at 4.5 years, with an acute exacerbation of chronic asthma. At presentation, he had hypotension, hypoglycaemia and normal electrolytes. He was given IV hydrocortisone to treat his severe asthma, and his lip hyperpigmentation was thought to be central cyanosis. Two weeks later, his lips remained dark, and cortisol was low, with markedly elevated ACTH. Family history revealed a sister aged 22 years with cerebral palsy and a healthy 15-year-old brother, who were both severely pigmented with high ACTH levels. The diagnosis of FGD type 2 was confirmed by identifying a homozygous missense mutation (p.Y59D) in MRAP in the three siblings. CONCLUSIONS: FGD can be easily overlooked during acute illness. In a sick child, paired measurement of serum cortisol with ACTH prior to starting steroid therapy would be useful in making the diagnosis of FGD.
UNLABELLED: Familial glucocorticoid deficiency (FGD) is a heterogeneous condition of isolated glucocorticoid deficiency due to adrenocorticotropic hormone (ACTH) resistance. Patients have adrenal failure with normal electrolytes. We report two Arab children with different forms of FGD, in whom the diagnosis was initially masked by their acute illness and discuss the reasons for the delay in the diagnosis of FGD in both patients. Patient 1 presented at 12 days with Serratia sepsis. She received hydrocortisone for septic shock and needed dexamethasone courses to wean her off ventilation. At 13 weeks, she had normal electrolytes, low cortisol and high ACTH in keeping with FGD. A homozygous missense mutation (T159) in MC2R confirmed the diagnosis of FGD type 1. Patient 2 was admitted at 4.5 years, with an acute exacerbation of chronic asthma. At presentation, he had hypotension, hypoglycaemia and normal electrolytes. He was given IV hydrocortisone to treat his severe asthma, and his lip hyperpigmentation was thought to be central cyanosis. Two weeks later, his lips remained dark, and cortisol was low, with markedly elevated ACTH. Family history revealed a sister aged 22 years with cerebral palsy and a healthy 15-year-old brother, who were both severely pigmented with high ACTH levels. The diagnosis of FGD type 2 was confirmed by identifying a homozygous missense mutation (p.Y59D) in MRAP in the three siblings. CONCLUSIONS: FGD can be easily overlooked during acute illness. In a sick child, paired measurement of serum cortisol with ACTH prior to starting steroid therapy would be useful in making the diagnosis of FGD.
Authors: Louise A Metherell; J Paul Chapple; Sadani Cooray; Alessia David; Christian Becker; Franz Rüschendorf; Danielle Naville; Martine Begeot; Bernard Khoo; Peter Nürnberg; Angela Huebner; Michael E Cheetham; Adrian J L Clark Journal: Nat Genet Date: 2005-01-16 Impact factor: 38.330
Authors: Eirini Meimaridou; Claire R Hughes; Julia Kowalczyk; Leonardo Guasti; J Paul Chapple; Peter J King; Li F Chan; Adrian J L Clark; Louise A Metherell Journal: Mol Cell Endocrinol Date: 2012-12-29 Impact factor: 4.102
Authors: C R Hughes; T T Chung; A M Habeb; F Kelestimur; A J L Clark; L A Metherell Journal: J Clin Endocrinol Metab Date: 2010-04-28 Impact factor: 5.958
Authors: Claire R Hughes; Leonardo Guasti; Eirini Meimaridou; Chen-Hua Chuang; John C Schimenti; Peter J King; Colm Costigan; Adrian J L Clark; Louise A Metherell Journal: J Clin Invest Date: 2012-02-22 Impact factor: 14.808
Authors: Eirini Meimaridou; Julia Kowalczyk; Leonardo Guasti; Claire R Hughes; Florian Wagner; Peter Frommolt; Peter Nürnberg; Nicholas P Mann; Ritwik Banerjee; H Nurcin Saka; J Paul Chapple; Peter J King; Adrian J L Clark; Louise A Metherell Journal: Nat Genet Date: 2012-05-27 Impact factor: 38.330
Authors: Louise A Metherell; Danielle Naville; George Halaby; Martine Begeot; Angela Huebner; Gudrun Nürnberg; Peter Nürnberg; Jane Green; Jeremy W Tomlinson; Nils P Krone; Lin Lin; Michael Racine; Dan M Berney; John C Achermann; Wiebke Arlt; Adrian J L Clark Journal: J Clin Endocrinol Metab Date: 2009-09-22 Impact factor: 5.958
Authors: T T Chung; T R Webb; L F Chan; S N Cooray; L A Metherell; P J King; J P Chapple; A J L Clark Journal: J Clin Endocrinol Metab Date: 2008-10-07 Impact factor: 5.958
Authors: Abdulaziz Alsaedi; Naglaa M Kamal; Ayman Bakkar; Enad Althobaiti; Muhammad Naeem; Mohamed Kamal Journal: Clin Med Insights Case Rep Date: 2022-04-08